Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation

Authors

Keywords

Journal

Volume 3, Issue Suppl 2, Pages P445

Publisher

Springer Nature

Online

2015-11-05

DOI

10.1186/2051-1426-3-s2-p445

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started